• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Tyrosine–tRNA ligase, Cytoplasmic domain (YARS1)

Recombination of a plasmid encoding the Human YARS1 protein (2-528aa) is the first step during the production the recombinant Human YARS1 protein. The constructed plasmid is introduced into e.coli cells. e.coli cells that can survive in the presence of a specific antibiotic are selected to be cultured for the induction of protein expression. The protein is equipped with a N-terminal GST tag. After expression, affinity purification is used to isolate and purify the recombinant Human YARS1 protein from the cell lysate. Denaturing SDS-PAGE is then applied to resolve the resulting recombinant Human YARS1 protein. Its purity exceeds 90%.

ACP03075

Recombination of a plasmid encoding the Human YARS1 protein (2-528aa) is the first step during the production the recombinant Human YARS1 protein. The constructed plasmid is introduced into e.coli cells. e.coli cells that can survive in the presence of a specific antibiotic are selected to be cultured for the induction of protein expression. The protein is equipped with a N-terminal GST tag. After expression, affinity purification is used to isolate and purify the recombinant Human YARS1 protein from the cell lysate. Denaturing SDS-PAGE is then applied to resolve the resulting recombinant Human YARS1 protein. Its purity exceeds 90%.

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP03075 Target NameYARS1
Target SynonymsCMTDIC; SYYC_HUMAN; Tyrosine tRNA ligase, cytoplasmic; Tyrosine tRNA ligase 1, cytoplasmic; Tyrosyl tRNA synthetase; Tyrosyl--tRNA ligase; Tyrosyl-tRNA synthetase, cytoplasmic; TyrRS; yars; YRS; YTSFormLiquid or Lyophilized powder
Expression SystemE.coliExpression Range2-528aa
Mol Weight86.0kDaProtein LengthFull Length of Mature Protein
PurityGreater than 90% as determined by SDS-PAGE.Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDP54577
Background Information
  • Uniprot Id

    P54577

  • Target Species

    Human

  • Target Name

    YARS

  • Target Full Name

    Tyrosine--tRNA ligase, cytoplasmic

  • Target Function

    Catalyzes the attachment of tyrosine to tRNA(Tyr) in a two-step reaction: tyrosine is first activated by ATP to form Tyr-AMP and then transferred to the acceptor end of tRNA(Tyr).

  • Target Involvement

    Charcot-Marie-Tooth disease, dominant, intermediate type, C (CMTDIC)

  • Target Subcellular Location

    Cytoplasm.

  • Target Protein Families

    Class-I aminoacyl-tRNA synthetase family

  • Target Research Area

    Metabolism

  • Target Synonyms

    CMTDIC; SYYC_HUMAN; Tyrosine tRNA ligase, cytoplasmic; Tyrosine tRNA ligase 1, cytoplasmic; Tyrosyl tRNA synthetase; Tyrosyl--tRNA ligase; Tyrosyl-tRNA synthetase, cytoplasmic; TyrRS; yars; YRS; YTS

  • Target Background

    Aminoacyl-tRNA synthetases catalyze the aminoacylation of tRNA by their cognate amino acid. Because of their central role in linking amino acids with nucleotide triplets contained in tRNAs, aminoacyl-tRNA synthetases are thought to be among the first proteins that appeared in evolution. Tyrosyl-tRNA synthetase belongs to the class I tRNA synthetase family. Cytokine activities have also been observed for the human tyrosyl-tRNA synthetase, after it is split into two parts, an N-terminal fragment that harbors the catalytic site and a C-terminal fragment found only in the mammalian enzyme. The N-terminal fragment is an interleukin-8-like cytokine, whereas the released C-terminal fragment is an EMAP II-like cytokine.

Inquire Recombinant Human Tyrosine–tRNA ligase, Cytoplasmic domain (YARS1) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification